Agonist-induced changes in the phosphorylation of the myosin- binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle
UMass Chan Affiliations
Department of PhysiologyDocument Type
Journal ArticlePublication Date
2002-09-26Keywords
Amino Acid SequenceAnimals
Molecular Sequence Data
Muscle Proteins
Muscle, Smooth
Myosin-Light-Chain Phosphatase
Myosins
Phosphoprotein Phosphatases
Phosphoproteins
Phosphorylation
Protein Binding
Rabbits
Recombinant Proteins
Physiology
Metadata
Show full item recordAbstract
The inhibition of myosin light chain phosphatase (MLCP) enhances smooth muscle contraction at a constant [Ca2+]. There are two components, myosin-binding subunit of MLCP (MBS) and CPI17, thought to be responsible for the inhibition of MLCP by external stimuli. The phosphorylation of MBS at Thr-641 and of CPI17 at Thr-38 inhibits the MLCP activity in vitro. Here we determined the changes in the phosphorylation of MBS and CPI17 after agonist stimulation in intact as well as permeabilized smooth muscle strips using phosphorylation-site-specific antibodies as probes. The CPI17 phosphorylation transiently increased after agonist stimulation in both alpha-toxin skinned and intact fibres. The time course of the increase in CPI17 phosphorylation after stimulation correlated with the increase in myosin regulatory light chain (MLC) phosphorylation. The increase in CPI17 phosphorylation was significantly diminished by Y27632, a Rho kinase inhibitor, and GF109203x, a protein kinase C inhibitor, suggesting that both the protein kinase C and Rho kinase pathways influence the change in CPI17 phosphorylation. On the other hand, a significant level of MBS phosphorylation at Thr-641, an inhibitory site, was observed in the resting state for both skinned and intact fibres and the agonist stimulation did not significantly alter the MBS phosphorylation level at Thr-641. While the removal of the agonist markedly decreased MLC phosphorylation and induced relaxation, the phosphorylation of MBS was unchanged, while CPI17 phosphorylation markedly diminished. These results strongly suggest that the phosphorylation of CPI17 plays a more significant role in the agonist-induced increase in myosin phosphorylation and contraction of smooth muscle than MBS phosphorylation in the Ca2+-independent activation mechanism of smooth muscle contraction.Source
Biochem J. 2003 Jan 1;369(Pt 1):117-28. Link to article on publisher's siteDOI
10.1042/BJ20021040Permanent Link to this Item
http://hdl.handle.net/20.500.14038/39392PubMed ID
12296769Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1042/BJ20021040
Scopus Count
Collections
Related items
Showing items related by title, author, creator and subject.
-
Positioning of AMPA Receptor-Containing Endosomes Regulates Synapse ArchitectureEsteves da Silva, Marta; Adrian, Max; Schatzle, Philipp; Lipka, Joanna; Watanabe, Takuya; Cho, Sukhee; Futai, Kensuke; Wierenga, Corette J.; Kapitein, Lukas C.; Hoogenraad, Casper C. (2015-11-03)Lateral diffusion in the membrane and endosomal trafficking both contribute to the addition and removal of AMPA receptors (AMPARs) at postsynaptic sites. However, the spatial coordination between these mechanisms has remained unclear, because little is known about the dynamics of AMPAR-containing endosomes. In addition, how the positioning of AMPAR-containing endosomes affects synapse organization and functioning has never been directly explored. Here, we used live-cell imaging in hippocampal neuron cultures to show that intracellular AMPARs are transported in Rab11-positive recycling endosomes, which frequently enter dendritic spines and depend on the microtubule and actin cytoskeleton. By using chemically induced dimerization systems to recruit kinesin (KIF1C) or myosin (MyosinV/VI) motors to Rab11-positive recycling endosomes, we controlled their trafficking and found that induced removal of recycling endosomes from spines decreases surface AMPAR expression and PSD-95 clusters at synapses. Our data suggest a mechanistic link between endosome positioning and postsynaptic structure and composition.
-
Motor function of unconventional myosinIkebe, Mitsuo; Inoue, Akira; Nishikawa, So; Homma, Kazuaki; Tanaka, Hiroto; Iwane, Atsuko Hikikoshi; Katayama, Eisaku; Ikebe, Reiko; Yanagida, Toshio (2004-04-22)
-
F-actin and myosin II binding domains in supervillinChen, Yu; Takizawa, Norio; Crowley, Jessica Lynn; Oh, Sang W.; Gatto, Cheryl Lynn; Kambara, Taketoshi; Sato, Osamu; Li, Xiang-Dong; Ikebe, Mitsuo; Luna, Elizabeth J. (2003-08-15)Detergent-resistant membranes contain signaling and integral membrane proteins that organize cholesterol-rich domains called lipid rafts. A subset of these detergent-resistant membranes (DRM-H) exhibits a higher buoyant density ( approximately 1.16 g/ml) because of association with membrane skeleton proteins, including actin, myosin II, myosin 1G, fodrin, and an actin- and membrane-binding protein called supervillin (Nebl, T., Pestonjamasp, K. N., Leszyk, J. D., Crowley, J. L., Oh, S. W., and Luna, E. J. (2002) J. Biol. Chem. 277, 43399-43409). To characterize interactions among DRM-H cytoskeletal proteins, we investigated the binding partners of the novel supervillin N terminus, specifically amino acids 1-830. We find that the supervillin N terminus binds directly to myosin II, as well as to F-actin. Three F-actin-binding sites were mapped to sequences within amino acids approximately 280-342, approximately 344-422, and approximately 700-830. Sequences with combinations of these sites promote F-actin cross-linking and/or bundling. Supervillin amino acids 1-174 specifically interact with the S2 domain in chicken gizzard myosin and nonmuscle myosin IIA (MYH-9) but exhibit little binding to skeletal muscle myosin II. Direct or indirect binding to filamin also was observed. Overexpression of supervillin amino acids 1-174 in COS7 cells disrupted the localization of myosin IIB without obviously affecting actin filaments. Taken together, these results suggest that supervillin may mediate actin and myosin II filament organization at cholesterol-rich membrane domains.